PepGen Inc. (PEPG)
US Market

PepGen Inc. (PEPG) Stock Price & Analysis


PEPG Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$4.32 - $20.00
Previous Close$15.29
Average Volume (3M)40.04K
Market Cap
Enterprise Value$220.06M
Total Cash (Recent Filing)$165.40M
Total Debt (Recent Filing)$21.83M
Price to Earnings (P/E)-4.6
Aug 11, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.33
Shares Outstanding23,782,297
10 Day Avg. Volume60,395
30 Day Avg. Volume40,038
Standard Deviation0.18
Financial Highlights & Ratios
Price to Book (P/B)2.06
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-5.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-3.06
Price Target Upside52.58% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was PepGen Inc.’s price range in the past 12 months?
PepGen Inc. lowest stock price was $4.32 and its highest was $20.00 in the past 12 months.
    What is PepGen Inc.’s market cap?
    Currently, no data Available
    When is PepGen Inc.’s upcoming earnings report date?
    PepGen Inc.’s upcoming earnings report date is Aug 11, 2023 which is in 75 days.
      How were PepGen Inc.’s earnings last quarter?
      PepGen Inc. released its earnings results on May 11, 2023. The company reported -$0.69 earnings per share for the quarter, beating the consensus estimate of -$0.792 by $0.102.
        Is PepGen Inc. overvalued?
        According to Wall Street analysts PepGen Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does PepGen Inc. pay dividends?
          PepGen Inc. does not currently pay dividends.
          What is PepGen Inc.’s EPS estimate?
          PepGen Inc.’s EPS estimate is -$0.81.
            How many shares outstanding does PepGen Inc. have?
            PepGen Inc. has 23,782,297 shares outstanding.
              What happened to PepGen Inc.’s price movement after its last earnings report?
              PepGen Inc. reported an EPS of -$0.69 in its last earnings report, beating expectations of -$0.792. Following the earnings report the stock price went down -2.931%.
                Which hedge fund is a major shareholder of PepGen Inc.?
                Among the largest hedge funds holding PepGen Inc.’s share is RA Capital Management. It holds PepGen Inc.’s shares valued at 99M.


                  PepGen Inc. Stock Smart Score

                  The PepGen Inc. stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  PepGen Inc.

                  PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases.


                  Top 5 ETFs holding PEPG

                  Market Value
                  Smart Score
                  iShares NASDAQ US Biotechnology UCITS ETF
                  Invesco Nasdaq Biotechnology ETF
                  Up to five ETFs with an Outperform Smart Score that hold PEPG. The ETFs are listed according to market value of PEPG within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Organogenesis Holdings
                  Protagonist Therapeutics
                  MiMedx Group

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis